Overall rank by patents
#44,872
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Anaeropharma Science, Inc.
USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, active 2016–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
5
Total patents granted
7
CPC technology areas
14.2
Avg claims per patent
-33%
5-year filing velocity
The verdict
Anaeropharma holds 5 US patents across 7 technology areas, rank #44,872 of 50,000 tracked assignees.
- #44,872
- of 50,000 US assignees by volume
- Top 86%
- by Innovation Score (24.1/100)
- 14.2
- avg claims per patent
- -33%
- filing velocity, last 5 yrs
Portfolio overview
Anaeropharma Science, Inc. has been granted 5 US utility patents between 2016 and 2021, placing Anaeropharma Science, Inc. at rank #44,872 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.2 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Anaeropharma Science, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Anaeropharma sits between Amtek Semiconductor Co., Ltd. (5 patents, rank #44,868) and Anchor Semiconductor, Inc. (5 patents, rank #44,876) - the closest US assignees by grant volume. The composite Innovation Score of 24.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 3 in the 2015–2019 window, a -33% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Anaeropharma Science, Inc.'s 14.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Anaeropharma Science, Inc. against peers pursuing similar technology classes.
Who files at Anaeropharma's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Amtek Semiconduct…
Amtek Semiconductor Co., Ltd.
5 patents
- Amundson Technolo…
Amundson Technology, LLC
5 patents
- Anapp
AnApp Technologies Limited
5 patents
- Anabio
Anabio Technologies Limited
5 patents
- Analog Modules
Analog Modules, Inc.
5 patents
- Anatomacl
AnatomACL, LLC
5 patents
- Anchor Innovation…
Anchor Innovation Medical, Inc.
5 patents
- Anchor Semiconduc…
Anchor Semiconductor, Inc.
5 patents
- Anaeropharma Scie… ◀
Anaeropharma Science, Inc.
5 patents
What this shows Anaeropharma holds 5 patents at rank #44,872, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Anaeropharma
By rank, the assignees closest to #44,872 in granted patent volume.
- Amtek Semiconductor Co., Ltd. #44,868 · 5 patents
- Amundson Technology, Llc #44,869 · 5 patents
- Anapp Technologies Limited #44,870 · 5 patents
- Anabio Technologies Limited #44,871 · 5 patents
- Analog Modules, Inc. #44,873 · 5 patents
- Anatomacl, Llc #44,874 · 5 patents
- Anchor Innovation Medical, Inc. #44,875 · 5 patents
- Anchor Semiconductor, Inc. #44,876 · 5 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Anaeropharma's primary technology class.
- Monsanto Technology Llc 1,335 in class
- The Regents Of The University Of California 1,161 in class
- Novozymes A/s 656 in class
- Immatics Biotechnologies Gmbh 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President And Fellows Of Harvard College 594 in class
- Massachusetts Institute Of Technology 541 in class
- The Trustees Of The University Of Pennsylvania 537 in class
Anaeropharma's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
24 Top 86% higher than 14% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 20.0% |
| 2017 | 1 | 20.0% |
| 2019 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
Which technologies does Anaeropharma Science, Inc. patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Anaeropharma Science, Inc. hold?
Anaeropharma Science, Inc. holds 5 US granted patents filed between 2016 and 2021, spanning 7 technology areas.
What is Anaeropharma Science, Inc.'s Innovation Score?
Anaeropharma Science, Inc. has an Innovation Score of 24.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Anaeropharma Science, Inc. focus on?
Anaeropharma Science, Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 5 patents. The company has filed patents in 7 CPC subclasses total.
Is Anaeropharma Science, Inc.'s patent filing rate increasing or decreasing?
Anaeropharma Science, Inc.'s recent filing velocity is -33% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Anaeropharma Science, Inc.'s patents?
Anaeropharma Science, Inc.'s patents average 14.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the Anaeropharma Science, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Anaeropharma's 5 grants land it in the top 86% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Anaeropharma ranks #44,872 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.